🔎 Trials Near Me

Beranda › Limfoma Burkitt › New Jersey › Edison

Uji klinis Limfoma Burkitt di Edison, NJ

5 studi untuk Limfoma Burkitt mencari peserta di lokasi sekitar Edison (dalam radius sekitar 30 mil). Buka studi untuk melihat kriteria peserta dan cara menghubungi tim studi.

Teks studi resmi (Bahasa Inggris)

Merekrut peserta untuk studi di sini? Tampilkan di bagian atas halaman ini — $99 selama 30 hari →

A Study Testing the Combination of Dasatinib or Imatinib to Chemotherapy Treatment With Blinatumomab for Children, Adolescents, and Young Adults With Philadelphia Chromosome Positive (Ph+) or ABL-Class Philadelphia Chromosome-Like (Ph-Like) B-cell Acute Lymphoblastic Leukemia (B-ALL)

Menerima pesertaFase 2
  • Rutgers Cancer Institute of New Jersey-Robert Wood Johnson University Hospital, New Brunswick · 3 mi jauhnya
366 Days – 46 Years · Semua jenis kelamin · Diperbarui 2 Okt 2026 · NCT06124157

Testing the Addition of the Anti-cancer Drug Venetoclax and/or the Anti-cancer Immunotherapy Blinatumomab to the Usual Chemotherapy Treatment for Infants With Newly Diagnosed KMT2A-rearranged or KMT2A-non-rearranged Leukemia

Menerima pesertaFase 2
  • Rutgers Cancer Institute of New Jersey-Robert Wood Johnson University Hospital, New Brunswick · 3 mi jauhnya
365 Days · Semua jenis kelamin · Diperbarui 25 Sep 2026 · NCT06317662

Substudy 01A: Zilovertamab Vedotin in Pediatric and Young Adult Participants With Hematologic Malignancies or Solid Tumors (MK-9999-01A/LIGHTBEAM-U01)

Menerima pesertaFase 1/2
  • Rutgers Cancer Institute of New Jersey ( Site 1008), New Brunswick · 3 mi jauhnya
6 Months – 25 Years · Semua jenis kelamin · Diperbarui 17 Sep 2026 · NCT06395103

A Study to Compare Blinatumomab Alone to Blinatumomab With Nivolumab in Patients Diagnosed With First Relapse B-Cell Acute Lymphoblastic Leukemia (B-ALL)

Menerima pesertaFase 2
  • Saint Peter's University Hospital, New Brunswick · 3 mi jauhnya
  • Rutgers Cancer Institute of New Jersey-Robert Wood Johnson University Hospital, New Brunswick · 3 mi jauhnya
  • Rutgers Cancer Institute of New Jersey, New Brunswick · 3 mi jauhnya
Usia 1 hingga 30 · Semua jenis kelamin · Diperbarui 1 Sep 2026 · NCT04546399

Inotuzumab Ozogamicin and Post-Induction Chemotherapy in Treating Patients With High-Risk B-ALL, Mixed Phenotype Acute Leukemia, and B-LLy

Menerima pesertaFase 3
  • Saint Peter's University Hospital, New Brunswick · 3 mi jauhnya
  • Rutgers Cancer Institute of New Jersey-Robert Wood Johnson University Hospital, New Brunswick · 3 mi jauhnya
365 Days – 25 Years · Semua jenis kelamin · Diperbarui 25 Agu 2026 · NCT03959085

Uji klinis Limfoma Burkitt di kota lain

Studi lain di Edison

Dari ClinicalTrials.gov, data diambil 5 Okt 2026. Setiap studi menetapkan kriteria kelayakannya sendiri; tim studi yang menentukan siapa yang bisa bergabung.